Chronic Total Occlusion
“For me, there is not another aspect in cardiology where cardiologists are able to provide the type of benefits that we see. Patients tell us literally on the table, they feel like they can take a breath again. For the first time in years they don’t have this constricting feeling around their chest."
– J. Aaron Grantham, MD
Dr. J. Aaron Grantham shares his most rewarding CTO patientView Video
Be the Next CTO Expert
Push the boundaries of innovation. Leverage the hybrid approach to treat chronic total occlusions safely – with maximum efficiency and success. Boston Scientific can help you build your CTO program with specialized training, unique tools, and ongoing case support. Partner with us to bridge coronary CTOs.
CTOs are very common, occurring in as many as 30% of patients with significant coronary artery disease.1,2
CABG vs PCI
Patients with CTOs are most often treated with medical therapy or coronary artery bypass graft (CABG) rather than PCI.
Recent meta-analyses and large registries have shown that successful CTO PCI is associated with symptom relief, a reduction in long-term mortality, and a lower need for coronary artery bypass graft (CABG) surgery.3,4,5